Smartkem Engages Anthony Amato to Support Specific Strategic Initiatives - Candlesense

Smartkem Engages Anthony Amato to Support Specific Strategic Initiatives

(NASDAQ:SMTK) MANCHESTER, England, Sept. 2, 2025 /PRNewswire/ -- Smartkem (Nasdaq: SMTK), which is seeking to change the world of electronics with a new class of transistor technology, today announced that it has engaged Anthony Amato and his firm, Bridge Associates International Pharmaceutical...